Psoriasis Clinical Trials

Showing 741-760 of 1,026 trials

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

NCT03424629

This is a study in patients with moderate to severe chronic plaque psoriasis.All the participants will be randomized into three groups, high-dose UC-MSCs, low-dose UC-MSCs, or methotrexate group.This study is designed to prove that UC-MSCs is safe and effective.

Moderate and Severe Plaque Psoriasis

Tianjin Ever Union Biotechnology Co., Ltd.57 participantsStarted Jun 2018

Beijing, China • Beijing, China

COMPLETEDNA

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

NCT03167515

The primary objective of this study is to determine the efficacy and safety of 074-6751 Lotion applied twice daily for four weeks (28 days) in clinical subjects with moderate plaque psoriasis.

Plaque Psoriasis

Ferndale Laboratories, Inc.95 participantsStarted May 2017

Tampa, Florida, United States • Carmel, Indiana, United States • Plainfield, Indiana, United States +2 more locations

COMPLETEDPhase 1

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

NCT02154425

The primary objectives of this study are to assess whether there is transfer of Certolizumab Pegol (CZP) into breast milk of lactating mothers who are receiving an established dosing regimen of CZP by evaluating the concentration of CZP in mature breast milk, and to calculate the daily infant dose of maternal CZP.

Axial Spondyloarthritis (AxSpA)Non-radiographic Evidence-AxSpAAnkylosing Spondylitis+3 more

UCB BIOSCIENCES, Inc.17 participantsStarted Sep 2014

Los Angeles, California, United States • Chapel Hill, North Carolina, United States • Durham, North Carolina, United States +3 more locations

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

Related Searches

A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Identification of New Prognostic Markers in Psoriatic Arthritis

Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis

Can We Miss Pigmented Lesions in Psoriasis Patients?

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034